Newly Diagnosed Multiple Myeloma Not Yet Recruiting Phase 2 Trials for Lenalidomide (DB00480)

IndicationStatusPhase
DBCOND0036257 (Newly Diagnosed Multiple Myeloma)Not Yet Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04052880Study of SubQ Dara With Dose-Attenuated Bortezomib, Lenalidomide, Dexamethasone in Elderly NDMMTreatment